Key points and analysis for on-site verification of drug clinical trial data after the implementation of the 2020 'Good Clinical Practice'

CAO Li-ya; XIE Lin-li; XIE Jiang-chuan; PAN Xin-mei; MA Pan; CHEN Yong-chuan

doi:10.3969/j.issn.1003-3734.2023.03.008

Home>Articles>Key points and analysis for on-site verification of drug clinical trial data after the implementation of the 2020 'Good Clinical Practice'

DOI: 10.3969/j.issn.1003-3734.2023.03.008

Key points and analysis for on-site verification of drug clinical trial data after the implementation of the 2020 'Good Clinical Practice'

CAO Li-ya

XIE Lin-li

XIE Jiang-chuan

PAN Xin-mei

MA Pan

CHEN Yong-chuan

Machine-generated Keywords：

Publication Date：2023-02-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 264-269 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2023,32(3)